These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vitamins A, B, C, D, E, F, trace elements and heavy metals: unapproved uses or indications. Nicolaidou E; Katsambas AD Clin Dermatol; 2000; 18(1):87-94. PubMed ID: 10701089 [No Abstract] [Full Text] [Related]
9. Hormones: androgens, antiandrogens, anabolic steroids, estrogens--unapproved uses or indications. Güneş AT; Fetil E Clin Dermatol; 2000; 18(1):55-61. PubMed ID: 10701086 [No Abstract] [Full Text] [Related]
16. Commentary: unapproved uses, dosages, or indications in dermatology: a physician's reference. Wolf R Clin Dermatol; 2002; 20(5):465-6. PubMed ID: 12435515 [No Abstract] [Full Text] [Related]
17. Off-label use of prescription drugs. Hill M Dermatol Nurs; 2000 Aug; 12(4):238, 256. PubMed ID: 11912659 [No Abstract] [Full Text] [Related]
18. Drug treatments for skin disease introduced in 2006. Skin Therapy Lett; 2007 May; 12(4):4-7. PubMed ID: 17551663 [TBL] [Abstract][Full Text] [Related]
19. Off-label uses of biologic agents in dermatology: a 2006 update. Kerns MJ; Graves JE; Smith DI; Heffernan MP Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Ara G; Teicher BA Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):3-16. PubMed ID: 8992490 [No Abstract] [Full Text] [Related] [Next] [New Search]